Chemoinformaics analysis of ETHYL 2,3-DIMETHOXYBENZOATE
| Molecular Weight | 210.229 | nRot | 4 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 7 |
| Exact Molecular Weight | 210.089 | nRing | 1 |
| Solubility: LogS | -2.54 | nHRing | 0 |
| Solubility: LogP | 2.33 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 30.9131 |
| nHD | 0 | BPOL | 20.1209 |
| QED | 0.712 |
| Synth | 1.592 |
| Natural Product Likeliness | -0.424 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.041 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.453 |
| MDCK | 0.0000337 |
| BBB | 0.551 |
| PPB | 0.607184 |
| VDSS | 0.733 |
| FU | 0.189759 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.926 |
| CYP2c19-sub | 0.831 |
| CYP2c9-inh | 0.373 |
| CYP2c9-sub | 0.838 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.877 |
| CYP3a4-inh | 0.211 |
| CYP3a4-sub | 0.398 |
| CL | 9.227 |
| T12 | 0.777 |
| hERG | 0.111 |
| Ames | 0.029 |
| ROA | 0.009 |
| SkinSen | 0.491 |
| Carcinogencity | 0.131 |
| EI | 0.967 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.071 |
| Antiviral | No |
| Prediction | 0.704674 |